Cargando…
Analysis of Lung Adenocarcinoma Subtypes Based on Immune Signatures Identifies Clinical Implications for Cancer Therapy
Lung cancer is the most common cause of cancer deaths worldwide, and lung adenocarcinoma (LUAD) is the most common histological subtype. However, the prognostic and predictive outcomes differ because of this cancer type heterogeneity. LUAD subtypes were identified on the basis of the immunogenomic p...
Autores principales: | Xu, Feng, Chen, Jie-xin, Yang, Xiong-bin, Hong, Xin-bin, Li, Zi-xiong, Lin, Ling, Chen, Yong-song |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183104/ https://www.ncbi.nlm.nih.gov/pubmed/32346613 http://dx.doi.org/10.1016/j.omto.2020.03.021 |
Ejemplares similares
-
Analysis of immune-related signatures of lung adenocarcinoma identified two distinct subtypes: implications for immune checkpoint blockade therapy
por: Wang, Qinghua, et al.
Publicado: (2020) -
Identification of lung adenocarcinoma subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genes
por: Hua, Linbin, et al.
Publicado: (2023) -
Identification and Validation of the Immune Subtypes of Lung Adenocarcinoma: Implications for Immunotherapy
por: Song, Yang, et al.
Publicado: (2020) -
Mining Database to Identify Aging-Related Molecular Subtype and Prognostic Signature in Lung Adenocarcinoma
por: Feng, Caihou, et al.
Publicado: (2022) -
Novel immune subtypes of lung adenocarcinoma identified through bioinformatic analysis
por: Qin, Fang‐lu, et al.
Publicado: (2020)